Blog
Discover our latest articles and blogs

Testosterone Cypionate Half-Life: How Long It Lasts
Testosterone cypionate has a label half-life of about eight days. See what that means for peak levels, dosing intervals and when to time your blood draw.

GLP-1 and Birth Control: What Changes and What Doesn't
Do GLP-1 drugs weaken birth control? Tirzepatide can lower pill absorption, semaglutide mostly doesn't. Learn who needs backup and what to ask your clinician.

GLP-1 Medicines and Cholesterol: What the Evidence Shows
How GLP-1 medicines such as semaglutide and tirzepatide affect LDL, HDL and triglycerides, what happens after stopping, and what to ask your clinician.

GLP-1 Maintenance Plan: What to Ask Before and After Goal Weight
What a GLP-1 maintenance plan involves after goal weight: dose decisions, spacing, regain data, lifestyle targets and questions to bring to your clinician.

Kisspeptin Therapy: What the Evidence and FDA Status Show
Kisspeptin therapy explained: how it affects LH and testosterone, what studies tested, how it compares with hCG, and its US regulatory status.

PT-141 Dosing: What the FDA Label Says About Bremelanotide
PT-141 (bremelanotide) dosing as the FDA label states it: dose, timing, monthly limits, side effects, cost, and how to prepare for a clinician visit.

Testosterone and Mood: What the Research Shows
Can testosterone therapy improve mood or depression? See what major trials show, who may benefit, the limits, and how to prepare questions for a clinician.

TRT and Prostate Health: What the Evidence Shows
Does testosterone therapy affect the prostate? See what FDA, VA and trial data say about cancer, BPH, PSA monitoring, blood pressure and heart risk.

Peptides With GLP-1: What Is Approved, What Isn't
GLP-1 medicines are peptides, but 'peptides with GLP-1' often means unapproved add-ons. See what the evidence says and what to ask a clinician.